関連する実験動画
Updated: Feb 13, 2026

09:11
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
22.5K
前立腺特異性ライソソームを標的とする退化剤の開発
Deqin Cai1, Xuankun Chen1, Yaxian Zhou1
1Lachman Institute of Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Journal of the American Chemical Society
|February 11, 2026
まとめ
研究者らは,前立腺がんに対する新しい標的型タンパク質分解 (TPD) 戦略を開発し,リソソームを標的とするPSMAを用いた. この方法は,膜および細胞外タンパク質を効果的に分解し,新しい精密医療の道を開きます.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
背景:
- 標的型タンパク質分解 (TPD) は,様々な疾患に対する有望な治療法である.
- 現在のTPD戦略は,膜および細胞外タンパク質の分解に限られている.
研究 の 目的:
- 前立腺がんのリゾソーム標的化分解戦略を開発する.
- 前立腺特異性膜抗原 (PSMA) をリソソームターゲティング受容体 (LTR) として利用する.
主な方法:
- リソソーム分解のためのPSMA TTargeting Chimeras (PTACs) を開発しました.
- 前立腺がん細胞における細胞外および膜タンパク質の分解をテストしたPTAC.
- 特定のPTAC (Ctx-L3,Atz-L5) の評価された分解力および選択性.
主要な成果:
- 標的タンパク質の選択的,強力,迅速,持続的なリソソーム分解が実証されています.
- Ctx-L3とAtz-L5.5を使用してEGFR (4.3 pM) とPD-L1 (2 pM) の例外的な分解能力を達成しました.
- PD-L1分解のための抗体および小分子形式のPTACの汎用性を示しました.
結論:
- PTACプラットフォームは,前立腺がんにおける細胞外および膜タンパク質の効果的なリソソーム分解を可能にします.
- このアプローチは,前立腺関連の疾患における精密医療のためのTPD技術を進歩させています.
関連する概念動画
Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Regulated Protein Degradation
3.2K
3.2K
Lysosomes
26.5K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
26.5K
Lysosomal Hydrolases
4.6K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.6K
Proteins: From Genes to Degradation
14.6K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.6K
Proteins: From Genes to Degradation
4.6K
4.6K

